Journal Of Clinical Oncology (jco) Podcast
Carboplatin-Gemcitabine-Bevacizumab: Expanding Treatment Options for Recurrent Platinum Sensitive Epithelial Ovarian Cancer
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:12:29
- More information
Informações:
Synopsis
Carboplatin-Gemcitabine-Bevacizumab represents an additional regimen to consider for management of recurrent platinum sensitive epithelial ovarian cancer, although it raises several questions regarding the role of bevacizumab in this disease setting.
